Net Income

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

A new integrated test from NeoGenomics aims to slash diagnostic delays and streamline complex tumor profiling, promising faster, smarter cancer treatment.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

The snack giant outpaced the market in 2025 with its core brands, but projects a dip in 2026 earnings despite growth plans and a new buyback program.

Samsung's new HBM4 memory delivers unprecedented speed and efficiency, setting a new bar for AI and reshaping the competitive semiconductor landscape.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

The clean fuel tech leader lands its first commercial aerospace order, leveraging its advanced carbon fiber composites for a demanding new frontier.

A new index reveals Indian small businesses are aggressively implementing sustainability, driven by profit motives, despite a surprising dip in awareness.

Estonian lender Bigbank AS taps private investors for a €3 million AT1 bond issuance, a strategic move to bolster its capital base amid ambitious growth plans.

Nektar Therapeutics secures a massive $400M offering, signaling strong investor faith in its lead drug, rezpegaldesleukin, for autoimmune diseases.

New data reveals Mesoblast's cell therapy Ryoncil dramatically boosts survival in GvHD patients when used early, paving the way for a major adult trial.

Gabelli Multimedia Trust maintains its high-yield distribution after a blockbuster 2025, but what does its 21% 'cash on cash' payout really mean for investors?

The insurer's double-digit dividend hike follows a year of record core earnings, rewarding shareholders and showcasing its robust financial health.

As Caroline Dorsa retires, Biogen elects Dr. Maria Freire as its new chair, a strategic move placing deep scientific expertise at the helm for a critical period.

Private equity firm Clairvest Group reports a 9% book value surge, driven by lucrative sales of F12.net and Acera, while acquiring a major US racino.

The specialty food giant adds Suntory Global Spirits CEO Greg Hughes to its board, a strategic move to leverage premium brand and operational expertise.

A new partnership with fintech firm april aims to ease the tax burden for consumers navigating debt settlement, setting a new standard for the industry.

As BJ’s prepares to report Q4 results, investors are watching if a pizza relaunch and new efficiencies can overcome industry-wide cost pressures.

With the hire of elite dealmaker George F. Schoen, the building materials giant is signaling a new era of aggressive M&A and strategic consolidation.